Vertiv Holdings Co (VRT) Vertiv Holdings Co, together with its subsidiaries, designs, manufactures, and services critical digital infrastructure technologies and life cycle services for data centers, communication networks, and commercial and industrial environments in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. TScan Therapeutics, Inc. (TCRX) TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops […]
Read MoreJasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique […]
Read MoreTalkspace, Inc. (TALK) Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. Praxis Precision Medicines, Inc. (PRAX) Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. Alpine Immune Sciences, Inc. (ALPN) Alpine Immune Sciences, Inc. operates as a clinical-stage […]
Read MorePraxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase IIb clinical trial for the treatment of essential tremor, as well as in Phase II clinical trial to treat […]
Read MoreDisc Medicine, Inc., together with its subsidiaries, operates as a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and […]
Read MoreDiversified Healthcare Trust (DHC) DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. Inter & Co, Inc. (INTR) Inter & Co, Inc., through its subsidiaries, engages in the banking and spending, investments, insurance brokerage businesses. Ardelyx, Inc. (ARDX) Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and […]
Read MoreWerewolf Therapeutics, Inc. (HOWL) Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. Bitfarms Ltd. (BITF) Bitfarms Ltd. engages in the mining of cryptocurrency coins and tokens in Canada, the United States, Paraguay, and Argentina. Y-mAbs Therapeutics, Inc. (YMAB) Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses […]
Read MoreSavara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Their lead product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Autoimmune PAP is a disease that belongs to a family of distinct, rare lung diseases collectively referred to as PAP. Autoimmune PAP […]
Read MoreNew Oriental Education & Technology Group Inc. (EDU) New Oriental Education & Technology Group Inc. provides private educational services under the New Oriental brand in the People’s Republic of China. MicroStrategy Incorporated (MSTR) MicroStrategy Incorporated provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. MacroGenics, Inc. (MGNX) MacroGenics, […]
Read MoreApellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria, cold agglutinin disease, C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, amyotrophic lateral sclerosis, and hematopoietic stem […]
Read MoreOlema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal […]
Read MoreRxSight, Inc. (RXST) RxSight, Inc., an ophthalmic medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. Geospace Technologies Corporation (GEOS) Geospace Technologies Corporation designs and manufactures instruments and equipment used in the oil and gas industry to acquire […]
Read MoreSoleno Therapeutics, Inc. (SLNO) Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. LuxUrban Hotels Inc. (LUXH) LuxUrban Hotels Inc. utilizes an asset light business model to lease entire hotels on a long-term basis and rent out hotel rooms in the properties […]
Read MoreMeta Platforms, Inc. (META) Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. Marvell Technology, Inc. (MRVL) Marvell Technology, Inc., together with its subsidiaries, provides data infrastructure semiconductor solutions, spanning the data center […]
Read MoreCymaBay Therapeutics, Inc. (CBAY) CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Autolus Therapeutics plc (AUTL) Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. Applied Therapeutics, Inc. (APLT) Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, […]
Read More